Benitec Biopharma Inc. develops a combination of gene therapy and RNA interference (gene silencing) to change treatment paradigms of human disease.

Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

COM:BENITEC

Benitec Biopharma Inc.

Last Close

10.20

22/11 21:00

Market Cap

264.90M

Beta: -

Volume Today

22.17K

Avg: -

Analysis Not Available